Press Release
February 27, 2020
Amphastar Pharmaceuticals Receives FDA Approval for Supplement to its Abbreviated New Drug Application for Sodium Bicarbonate Injection, USP 8.4%, 50mEq/50mL
More
January 28, 2020
Amphastar Announces the Receipt of a MINOR CRL for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial
More
November 27, 2019
Amphastar Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference
More
November 15, 2019
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
More
November 7, 2019
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2019
More
November 1, 2019
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 7th, 2019
More
August 29, 2019
Amphastar Pharmaceuticals to Present at the Wells Fargo 2019 Healthcare Conference
More
August 7, 2019
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2019
More
August 5, 2019
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2019
More
June 24, 2019